Should Moderna Before Aug.: A Clear Investor Guide for 2026
As Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
This volatility comparison pits the dividend aristocrats ETF against the SP500 to help you evaluate relative risk and inform allocation decisions.
20,523 articlesAs Aug. 5 looms, investors debate whether Moderna belongs in a refreshed portfolio. This guide breaks down the cataly...
Small-cap stocks are drawing attention as they surge alongside big-name AI leaders. This article breaks down the driv...
YieldMax's MSTY ETF continues to pay weekly distributions while its NAV slides, signaling rising risk for investors. ...
XDTE has drawn attention with a striking headline yield from zero-day-to-expiration options. This report examines the...
As quantum tech moves from lab to real-world use, two stocks stand out for 2026. This guide explains why IonQ and IBM...
A fresh look at how large holders deploy a bitcoin giant strategy and why Coinbase finds itself among the most shorte...
A major fund recently moved a sizable chunk of Osisko Development shares, prompting questions about what it means for...
Goldman Sachs-backed GPIQ is carving out a niche as a high-yield Nasdaq-100 income vehicle. The fund uses a laddered ...
With $500 in hand, the big question is where to invest for the best balance of growth and risk. This article compares...
Investors are weighing bets on critical metals as supply chains shift and demand from EVs and renewables climbs. This...
Alibaba is reshaping itself from a pure e-commerce giant into a cloud and AI contender. With profits under pressure a...
Major crypto assets slumped in a broad selloff, with Bitcoin and peers posting double-digit declines as market sentim...